News | February 02, 2022
Panacea Biotec sells its domestic formulations business to Mankind Pharma
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
The company performed particularly well in operational eco-efficiency, environmental and social reporting
Ranks among the top 15% companies globally
Bayer expects 2025 to be the most difficult year of its turnaround
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
The introduction of Coveris’ sleeve-to-sleeve PCR model complements sectors such as bottling where an established recycling infrastructure exists
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Subscribe To Our Newsletter & Stay Updated
